Neuraly (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 18, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $36,000,000
Company Info
- Founders
- Seulki Le
- Company Description
- Neuraly, a biotech company founded on technology created at the Johns Hopkins School of Medicine, is focused on the development of neuroprotective agents for neurologic disorders such as Alzheimer's disease and Parkinson's disease. In addition to NLY01, Neuraly's growing pipeline includes two candidates in early development targeting complementary mechanisms of neurodegenerative diseases.
- Market
- Neurologic disorders
- Location
- Germantown, MD, USA
- Coinvestors
- D&D Pharmatech, Dongkoo Bio&Pharma, Geon Investment, InterVest, LB Investment, Magna Investment, Maryland Venture Fund, Octave Life Sciences, Smilegate Investment